Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.8 SEK | 0.00% | -1.30% | +41.26% |
Mar. 13 | CombiGene's Epilepsy Project CG01 Receives Patent in Two New Countries | CI |
Feb. 21 | Orphazyme A/S acquired an additional unknown minority stake in CombiGene AB (OM:COMBI). | CI |
Chart calendar CombiGene AB
Upcoming events on CombiGene AB
Past events on CombiGene AB
2024-02-16 03:00 am | Q4 2023 Earnings Release |
2024-02-13 | Redeye Regenerative Medicine/Cell Therapy Event |
2023-11-10 03:00 am | Q3 2023 Earnings Release |
2023-10-24 | BioStock Life Science Fall Summit |
2023-08-25 03:00 am | Q2 2023 Earnings Release |
2023-05-24 | Annual General Meeting |
2023-05-12 03:00 am | Q1 2023 Earnings Release |
2023-02-22 12:00 am | Redeye Theme: Regenerative Medicine / Cell Therapy |
2023-02-17 03:00 am | FY 2022 Earnings Release |
2022-11-11 03:00 am | Q3 2022 Earnings Release |
2022-10-25 | Vator Securities Life Science Summit |
2022-08-25 03:00 am | Interim 2022 Earnings Release |
2022-05-19 04:00 am | Annual General Meeting |
2022-05-12 03:00 am | Q1 2022 Earnings Release |
2022-02-16 | FY 2021 Earnings Release |
2021-11-11 | Q3 2021 Earnings Release |
2021-10-07 05:20 am | Vator Securities Healthcare Innovation Summit |
2021-08-19 | Interim 2021 Earnings Release |
Annual results
Fiscal Period | December | 2018 | 2019 |
---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 0,01 0,00 - | 0,00 0,00 - |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million SEK | Released Forecast Spread | -13,2 -9,00 -46.46% | -17,7 -13,0 -36.08% |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - |
Net income | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - |
EPS | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - |
Announcement Date | 14/02/19 | 13/02/20 |
Past sector events for CombiGene AB
- Stock Market
- Equities
- COMBI Stock
- Calendar CombiGene AB